Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. BMY
BMY logo

BMY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BMY News

Dividend Investment Opportunities in Pfizer and Bristol Myers Squibb

12h agoFool

Top High-Dividend Stocks in Healthcare Sector

20h agoFool

Vanguard Research Bullish on U.S. Economic Outlook

3d agoFool

Vanguard Research Bullish on Value Stocks and Bonds

3d agoNASDAQ.COM

Roche's Divarasib Shows Positive Results in Late-Stage Study

4d agoNASDAQ.COM

Investment Choice Between Bristol Myers Squibb and Johnson & Johnson

6d agoFool

Investment Choice Between Bristol Myers Squibb and Johnson & Johnson

6d agoNASDAQ.COM

Market Capitalization Comparison: Dell vs. Bristol Myers

Jun 30 2026NASDAQ.COM

Analysis of the Importance of Market Capitalization

Jun 30 2026NASDAQ.COM

US House Committee Investigates Pharma Trials at Chinese Military Sites

Jun 30 2026seekingalpha

Analysis of BMY Dividend Predictions and Performance

Jun 30 2026NASDAQ.COM

Strategic Comparison of Johnson & Johnson and Bristol Myers Squibb

Jun 26 2026Fool

Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS

Jun 24 2026Globenewswire

Quantum BioPharma Advances Novel MS Drug Candidate Lucid-MS into Phase 2 Trials

Jun 24 2026Newsfilter

Calidi Biotherapeutics Appoints New Independent Director

Jun 24 2026NASDAQ.COM

Analysis of FDL's 52-Week High and Low Points

Jun 23 2026NASDAQ.COM